European Heart Journal Advance Access published online on July 24, 2006
European Heart Journal, doi:10.1093/eurheartj/ehl175
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 15123 Marousi, Athens, Greece; Department of Medicine, Tufts University School of Medicine, Boston, MA, USA; Department of Medicine, ‘Henry Dunant’ Hospital, Athens, Greece
* To whom correspondence should be addressed. Research findings presented in scientific conferences have a considerable direct and indirect impact on decision-making of clinicians. Investigators in various fields of research have examined the possible differences in aims, results, and conclusions between conference abstracts and subsequent corresponding published papers. They documented that differences between data presented in conference abstracts and published papers are frequent and occasionally major. These findings strongly support the position that we should not hurry to incorporate in clinical decision-making data presented at international or national scientific conferences. Instead, we believe that we better serve our patients by waiting at least for the evaluation of potential scientific advances by rigorous peer review.
Received June 19, 2006
Revised July 3, 2006
Accepted July 6, 2006
Current opinion
Clinical decision-making based on findings presented in conference abstracts: is it safe for our patients?
Matthew E. Falagas 1 * and Evangelos S. Rosmarakis 2
2 Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 15123 Marousi, Athens, Greece; Department of Cardiology, First IKA Hospital, Athens, Greece
Matthew E. Falagas, E-mail: m.falagas{at}aibs.gr
![]()
Abstract
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J P Leombruno, T R Einarson, and E C Keystone The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events Ann Rheum Dis, July 1, 2009; 68(7): 1136 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Z. Vardakas MD, I. I. Siempos MD, A. Grammatikos MD, Z. Athanassa MD, I. P. Korbila MD, and M. E. Falagas MD DSc Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials Can. Med. Assoc. J., December 2, 2008; 179(12): 1269 - 1277. [Abstract] [Full Text] [PDF] |
||||

